GlassScriptPhysician profile
Primo Andres
NPI 1538132808
$4,462.32
in general payments reported to CMS, 2019-2025
18 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,427 · 2020: $19.41 · 2021: $215 · 2022: $1,562 · 2023: $63.85 · 2024: $18.57 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,165.53 | 2019 | |
| Boston Scientific Corporation | $1,454.45 | 2019-2022 | |
| Pfizer INC. | $135.09 | 2019-2021 | |
| Novo Nordisk INC | $121.60 | 2025 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $105.43 | 2021 | |
| Abbott Laboratories | $102.38 | 2021-2023 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $72.65 | 2019 | |
| Amgen INC. | $46.63 | 2019 | |
| Janssen Pharmaceuticals, INC | $42.91 | 2022-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $39.52 | 2020-2021 | |
| Abiomed | $34.42 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.90 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $23.83 | 2021 | |
| Lilly USA, LLC | $20.19 | 2023 | Trulicity |
| Merck Sharp & Dohme LLC | $18.57 | 2024 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.90 | 2022 | |
| Cardiovascular Systems INC. | $15.90 | 2022 | |
| Esperion Therapeutics, INC. | $15.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Primo Andres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.